Lympro Chem Private Limited - chemicals and materials in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U24100MH2004PTC145403 Incorporated 29 March 2004 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company chemicals and materials MSME · Micro
Data last updated
Revenue · FY 2025
₹2.28 Cr
▼ 23% YoY
Net profit · FY 2025
₹3.51 Lakh
Net margin 1.5%
EBITDA · FY 2025
₹17.93 Lakh
EBITDA margin 7.9%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹3.51 Cr
Secured borrowings
Company age
22 yrs
Est. 2004
Directors on board
2
As per MCA filings

About Lympro Chem Private Limited

Data last updated:

Lympro Chem Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 29 March 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2004PTC145403. Its GSTIN is 27AAACL9810G1ZJ (Maharashtra).

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Padmakar Dwarakanath Saraf and Mangesh Padmakar Saraf.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Pl No. 1 Vishwa Vidisha Chs Rajaji Cross Road No 3 Dombivali East, Thane, Maharashtra, India – 421201.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.28 Cr, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹3.51 Lakh (net margin 1.5%) and EBITDA of ₹17.93 Lakh (EBITDA margin 7.9%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 3% over five years.

As per MCA filings, the company has open charges of ₹3.51 Cr on record. Court records list 7 cases involving the company, including 5 filed by the company and 2 filed against it; 2 cases are pending.

Lympro Chem Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0085233). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lymprochem.in.

Company Details of Lympro Chem Private Limited
CIN U24100MH2004PTC145403
Registration Number 145403
Incorporation Date 29 March 2004
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0085233

Recognitions & Rankings of Lympro Chem

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-33-0085233
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Pl No. 1 Vishwa Vidisha Chs Rajaji Cross Road No 3 Dombivali East, Thane, Maharashtra, India – 421201
  • Industry
    Chemicals and Materials, Industrial Chemicals
Comprehensive company report
Lympro Chem Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full report on Lympro Chem

Financials, compliance, directors, charges, ownership and filings for Lympro Chem Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity

The main business activity of Lympro Chem is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Financials of Lympro Chem Private Limited

FY 2024 filings available

Lympro Chem Private Limited reported revenue of ₹2.28 Cr (down 23% YoY) for FY 2025.

Revenue · FY 2025
₹2.28 Cr ▼ 23%
Net profit · FY 2025
₹3.51 Lakh margin 1.5%
EBITDA · FY 2025
₹17.93 Lakh margin 7.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 14%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 158%
3 years · compounded
▼ 17%
5 years · compounded
▼ 8%

Revenue fell 23% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA rose 158% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2020-21 to FY 2023-24in the company report
Profit and Loss Statement
Revenue from Operations••••
Other Income••••
Total Revenue••••
Cost of Materials Consumed••••
Employee Benefit Expense••••
Finance Costs••••
Depreciation and Amortisation••••
Other Expenses••••
Total Expenses••••
EBITDA₹17.93 Lakh
Profit Before Tax••••
Tax Expense••••
Net Profit (PAT)₹3.51 Lakh
Balance Sheet
Share Capital••••
Reserves and Surplus••••
Net Worth (Total Equity)••••
Long-term Borrowings••••
Short-term Borrowings••••
Trade Payables••••
Total Liabilities••••
Fixed Assets••••
Investments••••
Inventories••••
Trade Receivables••••
Cash and Bank Balance••••
Total Assets••••

Financial Ratios

MetricsFY 2024-25FY 2020-21 to FY 2023-24in the company report
Profitability
EBITDA Margin7.9%
Net Profit Margin1.5%
Return on Equity (ROE)••••
Return on Capital Employed (ROCE)••••
Return on Assets (ROA)••••
Liquidity and Debt
Current Ratio••••
Quick Ratio••••
Debt-to-Equity Ratio••••
Interest Coverage Ratio••••
Efficiency and Growth
Asset Turnover••••
Receivable Days••••
Payable Days••••
Inventory Days••••
Revenue Growth••••
Net Profit Growth••••

Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lympro Chem are in the company report.

Financial statements from 2015: available in the company report

Board of Directors of Lympro Chem Private Limited

Lympro Chem has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Padmakar Dwarakanath SarafDirector29 Mar 200422 Years 6 MonthsCurrent
Mangesh Padmakar SarafDirector29 Mar 200422 Years 6 MonthsCurrent

Peer Comparison

Lympro Chem Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Shako Organic Chemicals Private Limited₹2.3 Cr (FY 2025)••••••••152.0%••••Durgapur, West Bengal, India
Lympro Chem Private Limited this company₹2.28 Cr (FY 2025)••••••••-23.0%••••Thane, Maharashtra, India
Exigo Enterprises Private Limited₹2.28 Cr (FY 2023)••••••••284.0%••••Cuttack, Odisha, India
Rathi Health Care Private Limited₹2.27 Cr (FY 2025)••••••••37250.0%••••New Delhi, Delhi, India

Peers are the companies nearest to Lympro Chem by revenue, above and below it, in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details

Lympro Chem Private Limited is audited by NANDARSHI BHATT AND ASSOCIATES for the financial year 2023.

NameStatusAppointment DateCessation Date
NANDARSHI BHATT AND ASSOCIATESLockedLockedLocked

Complete auditor history: available in the company report

Ownership and Shareholding

Shareholding and ownership data: available in the company report

Charges & Borrowings

Open charges
₹3.51 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹2.23 Cr
Dombivli Nagari Sahakari Bank Ltd.₹1.28 Cr
Latest charge details
DateLenderAmountStatus
25 Mar 2025Others₹50 LakhOpen
28 Feb 2020Others₹23 LakhOpen
09 Nov 2010Dombivli Nagari Sahakari Bank Ltd.₹30 LakhOpen
04 Nov 2010Dombivli Nagari Sahakari Bank Ltd.₹90 LakhOpen
16 Aug 2009Dombivli Nagari Sahakari Bank Ltd.₹8 LakhOpen

Total charge records: 6 View all charges

MSME Payment Delays

Lympro Chem Private Limited has 5 MSME Form 1 returns on record between 2019 and 2021, listing 25 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 9)

SupplierAmount dueDue sinceReported on
Nyne Organics Private Limited••••••••••••
an individual supplier••••••••••••
Vertex Dye Chem••••••••••••
Vimal Intertrade Private Limited••••••••••••
an individual supplier••••••••••••

Full MSME payment history: available in the company report

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Employees and EPFO Compliance

Employment history and EPFO contributions of people linked to Lympro Chem.

Employee and EPFO history: available in the company report

Recent Activity

Lympro Chem Private Limited has 4 board changes on record since 2004: 2 appointments and 2 cessations. The latest: Anuja Mangesh Saraf ceased to be Additional Director on 30 Sep 2015.

Charges
A charge with Others amounted to Rs. 0.50 Cr with Charge ID 101081011 was registered on 25 Mar 2025.
AGM
Lympro Chem Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Lympro Chem Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 0.23 Cr with Charge ID 100331930 was registered on 28 Feb 2020.
Charges
A charge with Others of Rs. 1.50 Cr registered on 24 Sep 2004 with Charge ID 90151637 was modified on 28 Feb 2020.
Ceased
Anuja Mangesh Saraf ceased to be Additional Director.
Ceased
Archana Yogesh Saraf ceased to be Director.
Charges
A charge with Dombivli Nagari Sahakari Bank Ltd. amounted to Rs. 0.30 Cr with Charge ID 10256697 was registered on 09 Nov 2010.
Charges
A charge with Dombivli Nagari Sahakari Bank Ltd. amounted to Rs. 0.90 Cr with Charge ID 10261938 was registered on 04 Nov 2010.
Charges
A charge with Dombivli Nagari Sahakari Bank Ltd. amounted to Rs. 0.08 Cr with Charge ID 10173782 was registered on 16 Aug 2009.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 90151637 was registered on 24 Sep 2004.
Appointed
Mangesh Padmakar Saraf was appointed as Director.

2 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts

Credit ratings, litigation, and regulatory alerts: available in the company report

Subsidiaries & Group Companies

Corporate group structure: available in the company report

GST Compliance

Lympro Chem has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACL9810G1ZJMaharashtraActive01 Jul 2017

GST registrations and filing compliance: available in the company report

MCA Filings & Documents

MCA filings and documents: available in the company report

Frequently Asked Questions

Lympro Chem is an active private limited company based in Thane, Maharashtra, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 29 March 2004 (22+ years old) and is registered under CIN U24100MH2004PTC145403.

Lympro Chem has 2 current directors:

The latest financial statements of Lympro Chem on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Lympro Chem is 27AAACL9810G1ZJ, registered in Maharashtra.

The CIN (Corporate Identification Number) of Lympro Chem is U24100MH2004PTC145403. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Lympro Chem has 7 court cases on record: 5 filed by the company and 2 filed against it. 2 are pending.

Lympro Chem was incorporated on 29 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Lympro Chem by revenue are Shako Organic Chemicals Private Limited, Exigo Enterprises Private Limited, Rathi Health Care Private Limited, all in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Anuja Mangesh Saraf ceased to be Additional Director on 30 Sep 2015. Archana Yogesh Saraf ceased to be Director on 01 Sep 2015. Mangesh Padmakar Saraf was appointed as Director on 29 Mar 2004. Lympro Chem has 4 board changes on record in total.

Yes, Lympro Chem is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0085233).

Lympro Chem has 5 MSME Form 1 returns on record between 2019 and 2021, listing 25 overdue payments to 9 micro and small suppliers. The latest return was filed on 22 Jul 2021.

Lympro Chem can be reached through the website lymprochem.in. Its registered office is in Thane, Maharashtra, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available